|
ZFP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.99930000000159E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.029200E-04 |
| Normal-vs-Stage2 |
1.197810E-01 |
| Normal-vs-Stage3 |
6.95360000024792E-07 |
| Normal-vs-Stage4 |
1.93818999999484E-05 |
| Stage1-vs-Stage2 |
2.039200E-01 |
| Stage1-vs-Stage3 |
4.879000E-03 |
| Stage1-vs-Stage4 |
2.468200E-02 |
| Stage2-vs-Stage3 |
3.181200E-03 |
| Stage2-vs-Stage4 |
7.121500E-03 |
| Stage3-vs-Stage4 |
9.376800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.07749999997709E-06 |
| Normal-vs-AfricanAmerican |
2.627600E-02 |
| Normal-vs-Asian |
7.038500E-03 |
| Caucasian-vs-AfricanAmerican |
7.673400E-01 |
| Caucasian-vs-Asian |
1.429190E-01 |
| AfricanAmerican-vs-Asian |
6.656000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.180000E-03 |
| Normal-vs-Female |
3.63140000000373E-05 |
| Male-vs-Female |
5.571000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.922040E-03 |
| Normal-vs-Age(41-60Yrs) |
1.154580E-04 |
| Normal-vs-Age(61-80Yrs) |
4.36030000000587E-05 |
| Normal-vs-Age(81-100Yrs) |
3.548200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.113800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.359170E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.888600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.012800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.642400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.408200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.839100E-04 |
| Classical-VS-Follicular |
7.229600E-01 |
| Classical-VS-Other |
7.420000E-01 |
| Classical-VS-Normal |
3.990000E-04 |
| Tall-VS-Follicular |
6.428300E-04 |
| Tall-VS-Other |
1.723980E-01 |
| Tall-VS-Normal |
1.80430000051857E-07 |
| Follicular-VS-Other |
8.424800E-01 |
| Follicular-VS-Normal |
6.924800E-03 |
| Other-VS-Normal |
3.219400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.317640E-03 |
| Normal-vs-N1 |
1.71490000000496E-06 |
| N0-vs-N1 |
8.875300E-03 |
|
|
